Malaria Vaccine Took 30 Years. It's Still a Work in Progress

(Bloomberg) -- After more than three decades of work and almost $1 billion of investment, GlaxoSmithKline Plc and its partners are ready to deploy a vaccine for malaria, the mosquito-borne disease ...